Loading
Latest filing published 04 Sept 2025 for Protalix BioTherapeutics, Inc..
No signal scores available.
Our data holds just one disclosure by Christian Elze, dated 4 September 2025, reporting a share grant in Protalix BioTherapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration